The FDA’s tobacco regulatory decision-making process is so slow and
opaque that it’s ineffective, say legal, industry and public health
experts appearing before an outside panel conducting a
commissioner-mandated review of the program. Katherine Ellen Foley talks
with Ben Leonard. Plus, Greer Donley, a professor specializing in
reproductive health care at the University of Pittsburgh Law School,
breaks down what the FDA’s stance on doctors prescribing abortion pills
to people who aren’t yet pregnant means in practice.
view more